Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Following Approval, Triptorelin 6-Month Injection Now Available to Treat Central Precocious Puberty

Following Approval, Triptorelin 6-Month Injection Now Available to Treat Central Precocious Puberty

By

Gonadotropin-releasing hormone (GnRH) agonist Triptodur treats central precocious puberty via intramuscular injection.

Availability of Insulin Lispro Injection to Treat Diabetes

Availability of Insulin Lispro Injection to Treat Diabetes

By

Approved in June 2017, the Humalog Junior KwikPen will soon be available to treat patients with diabetes.

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

By

Multiple clinical studies have examined the efficacy of pitavastatin.

Reversing Type 1 Diabetes May Be Possible With Tuberculosis Vaccine

Reversing Type 1 Diabetes May Be Possible With Tuberculosis Vaccine

By

Data from a phase 1 study was presented at the 2017 ADA Scientific Sessions.

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

By

Data from the 9300 patient LEADER trial is now eligible for inclusion on liraglutide injection packaging.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters

CME Focus